SCHEMBL21035523

SCHEMBL21035523

O=C(O)[C@@H]1C[C@H](Oc2ccccc2)CN1S(=O)(=O)c1ccc2cc(OC3CCCC3)ccc2c1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 4/20 0.43
MMP1 P03956 4/20 0.43
MMP3 P08254 4/20 0.43
MMP9 P14780 2/20 0.43
ADAM17 P78536 1/20 0.43
AKR1C1 Q04828 1/20 0.43
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
KAT6A Q92794 1/20 0.41
HCRTR1 O43613 1/20 0.41
HCRTR2 O43614 1/20 0.41
MMP7 P09237 3/20 0.41
KDM4E B2RXH2 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ITGB1 P05556 1/20 0.39
ITGA4 P13612 1/20 0.39
HTR2C P28335 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21034984 0.95 CA12 (0.48) AKR1C3MMP1MMP3MMP9ADAM17
SCHEMBL21035346 0.95 CA12 (0.48) AKR1C3MMP1MMP3MMP9ADAM17
SCHEMBL21035399 0.92 HTR1A (0.44) AKR1C3MMP1MMP3MMP9ADAM17
SCHEMBL21035314 0.92 HTR1A (0.44) AKR1C3MMP1MMP3MMP9ADAM17
SCHEMBL21035522 0.90 MMP1 (0.43) AKR1C3MMP1MMP3MMP9ADAM17
SCHEMBL21036271 0.89 MMP9 (0.42) AKR1C3MMP1MMP3MMP9ADAM17
SCHEMBL21035657 0.88 MMP9 (0.43) AKR1C3MMP1MMP3MMP9ADAM17
SCHEMBL21034975 0.88 MMP9 (0.43) AKR1C3MMP1MMP3MMP9ADAM17
SCHEMBL21035352 0.86 CA12 (0.46) MMP1MMP3MMP9ADAM17CA12
SCHEMBL21034977 0.86 CA12 (0.46) MMP1MMP3MMP9ADAM17CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019104011-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2019-05-31 WO disclosed